XML 27 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock Options And Warrants
6 Months Ended
Jun. 30, 2018
Stock Options And Warrants  
Stock Options and Warrants

10.  STOCK OPTIONS AND WARRANTS

Stock Options

On July 10, 2003, the Company adopted the Warp 9, Inc. Stock Option Plan for directors, executive officers, and employees of and key consultants to the Company. Pursuant to the now terminated plan, the Company could issue 5,000,000 shares of common stock. The plan was administered by the Company’s Board of Directors, and options granted under the plan could be either incentive options or nonqualified options. Each option was exercisable in full or in installment and at such time as designated by the Board. Notwithstanding any other provision of the plan or of any option agreement, each option expired on the date specified in the option agreement, which date was to be no later than the tenth anniversary of the date on which the option was granted (fifth anniversary in the case of an incentive option granted to a greater-than-10% stockholder). The purchase price per share of the common stock under each incentive option was to be no less than the fair market value of the common stock on the date the option was granted (110% of the fair market value in the case of a greater-than-10% stockholder). The purchase price per share of the common stock under each nonqualified option was to be specified by the Board at the time the option is granted, and could be less than, equal to or greater than the fair market value of the shares of common stock on the date such nonqualified option was granted, but was to be no less than the par value of shares of common stock. The plan provided specific language as to the termination of options granted thereunder.

On August 1, 2017, we granted non-qualified stock options to purchase up to 10,000,000 shares of our common stock to Jill Giles, at a price of $0.01 per share. The stock options vest equally over a period of 36 months and expire August 1, 2022.

On September 18, 2017, we granted non-qualified stock options to purchase up to 1,800,000 shares of our common stock to three key employees, at a price of $0.05 per share. The stock options vest equally over a period of 36 months and expire September 18, 2022.

On January 3, 2018, we granted non-qualified stock options to purchase up to 20,000,000 shares of our common stock to three key employees, at a price of $0.04 per share. The stock options vest equally over a period of 36 months and expire January 3, 2023.

The Company used the historical industry index to calculate volatility, since the Company’s stock history did not represent the expected future volatility of the Company’s common stock. The fair value of options granted during the six months ended June 30, 2018 and year ended December 31, 2017, were determined using the Black Scholes method with the following assumptions:

 

   Six months ended  Year ended
   June 30, 2018  December 31, 2017
Risk free interest rate   5.00%   5.00%
Stock volatility factor   397%   397%
Weighted average expected option life   5 years    5 years 
Expected dividend yield   none    none 

 

A summary of the Company’s stock option activity and related information follows:

     Six Months ended
June 30, 2018
   Six Months ended
June 30, 2017
        Weighted average       Weighted average
    Options   exercise price   Options   exercise price
Outstanding -beginning of period     134,800,000     $ 0.013       123,000,000     $ 0.013  
Granted     20,000,000     $ 0.040       —       $ —    
Exercised     —       $ —         —       $ —    
Forfeited     —       $ —         —       $ —    
Outstanding - end of period     154,800,000     $ 0.017       123,000,000     $ 0.013  
Exercisable at the end of the period     125,738,995     $ 0.013       94,095,890     $ 0.012  
Weighted average fair value of                                
 options granted during the year           $ 800,000             $ —    

  

As of June 30, 2018 and December 31, 2017, the intrinsic value of the stock options was approximately $1,783,750 and $3,632,450, respectively. Stock option expense for the six months ended June 30, 2018 and 2017 was $285,976 and $248,937, respectively.

The Black Scholes option valuation model was developed for use in estimating the fair value of traded options, which do not have vesting restrictions and are fully transferable. In addition, option valuation models require the input of highly subjective assumptions, including the expected stock price volatility. Because the Company’s employee stock options have characteristics significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect the fair value estimate, in management’s opinion, the existing models do not necessarily provide a reliable single measure of the fair value of its employee stock options.

The weighted average remaining contractual life of options outstanding, as of June 30, 2018 was as follows:

   Number of  Weighted Average
Exercise  options  remaining contractual
prices  outstanding  life (years)
$0.05    1,800,000    4.22 
$0.04    20,000,000    4.52 
$0.02    35,000,000    4.16 
$0.01    60,000,000    3.6 
$0.01    15,000,000    3.72 
$0.01    10,000,000    4.09 
$0.005    12,500,000    1.12 
$0.004    500,000    3.29 
      154,800,000      

  

Warrants

During the six months ended June 30, 2018 and 2017, the Company issued no warrants for services, and no warrants were outstanding.